![]() |
![]() |
![]() |
![]() |
![]() |
|
|
Washington, D.C., March 29, 2001--Bringing together the panoply of human subjects research stakeholders-clinical investigators, patient representatives, medical school, teaching hospital and university leaders, and those from industry, law and the media-the Association of American Medical Colleges (AAMC) has named 28 members to its Task Force on Financial Conflicts of Interest in Clinical Research. The body is charged with assessing current AAMC guidelines on conflict of interest, and with formulating new principles that address both individual investigator and institutional concerns. AAMC President Jordan J. Cohen, M.D., announced the formation of the Task Force last November at the AAMC Annual Meeting in Chicago. Today, he said, "This new Task Force addresses one of the most significant issues the Association and its members face-sustaining public trust in research in which both the investigators and their institutions may hold financial interests. We have lots of ground to cover and the stakes are high; the public's support for medical research may turn on the ability of the academic community to police itself in ways that are credible." The Task Force Chair is William Danforth, M.D., chancellor emeritus of Washington University. "We have an excellent group with members who bring diverse perspectives to the task," said Dr. Danforth. "Our work is timely and important, especially because of the increased cooperation between business and academia, which brings with it new forms of financial rewards." Importantly, the Task Force membership includes national leaders from patient groups. Martin Delaney, Founding Director of Project Inform, a San Francisco-based HIV/AIDS information and advocacy organization, said, "Putting patients' interests first-ahead of financial and product sponsors of clinical trials-is one of the most basic goals of patient activism. I worry that people with life threatening illnesses, who often lack the support of organized activism so common in the AIDS community, are left to fend for themselves in an environment heavily influenced by corporate and academic goals. I'm very grateful for the opportunity to address these concerns through this Task Force." The Task Force anticipates completing its work in two years. It is charged with reviewing and updating the AAMC's 1990 guidelines on faculty conflicts of interest, and with developing a new set of principles for addressing institutional financial conflicts of interest in clinical research. As a starting point for its deliberations, the Task Force will consider the principles and guidelines recently developed by a group of prominent medical school leaders, convened by Harvard Medical School Dean Joseph B. Martin, M.D. A list of the members of the Task Force on Financial Conflicts of Interest in Clinical Research follows. Task Force on Financial Conflicts of Interest in Clinical Research Chair Academic Leadership Researchers Attorneys Ethicists Industry Journalists/Media Public/Patient Representatives Staff Association of American Universities Liaison ### The Association of American Medical Colleges represents the 125 accredited U.S. medical schools; the 16 accredited Canadian medical schools; some 400 major teaching hospitals, including 74 Veterans Administration medical centers; 91 academic and professional societies representing nearly 88,000 faculty members; and the nation's 67,000 medical students and 102,000 residents. |
|||
|
Contact Us © 1995-2008 AAMC Terms and Conditions Privacy Statement |